The emerging field of epigenetics in neurodegeneration and neuroprotection

被引:241
|
作者
Hwang, Jee-Yeon [1 ]
Aromolaran, Kelly A. [1 ]
Zukin, R. Suzanne [1 ]
机构
[1] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Rose F Kennedy Ctr, Room 610,1300 Morris Pk Ave, Bronx, NY 10461 USA
基金
美国国家卫生研究院;
关键词
RUBINSTEIN-TAYBI-SYNDROME; TRANSCRIPTION FACTOR REST; SCF-BETA-TRCP; SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE INHIBITION; GENOME-WIDE ANALYSIS; LONG NONCODING RNA; ALZHEIMERS-DISEASE; DNA METHYLATION; HUNTINGTONS-DISEASE;
D O I
10.1038/nrn.2017.46
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Epigenetic mechanisms - including DNA methylation, histone post-translational modifications and changes in nucleosome positioning - regulate gene expression, cellular differentiation and development in almost all tissues, including the brain. In adulthood, changes in the epigenome are crucial for higher cognitive functions such as learning and memory. Striking new evidence implicates the dysregulation of epigenetic mechanisms in neurodegenerative disorders and diseases. Although these disorders differ in their underlying causes and pathophysiologies, many involve the dysregulation of restrictive element 1-silencing transcription factor (REST), which acts via epigenetic mechanisms to regulate gene expression. Although not somatically heritable, epigenetic modifications in neurons are dynamic and reversible, which makes them good targets for therapeutic intervention.
引用
收藏
页码:347 / 361
页数:15
相关论文
共 50 条
  • [21] The role of the kynurenine pathway in neurodegeneration and neuroprotection
    Plangar, I.
    Zadori, D.
    Klivenyi, P.
    Fueloep, F.
    Toldi, J.
    Vecsei, L.
    7TH INTERNATIONAL CONGRESS ON THE IMPROVEMENT OF THE QUALITY OF LIFE ON DEMENTIA, PARKINSON'S DISEASE, EPILEPSY, MS, MUSCULAR DISORDERS AND NEUROETHICS, 2009, : 26 - +
  • [22] Exosomes: Mediators of Neurodegeneration, Neuroprotection and Therapeutics
    Kalani, Anuradha
    Tyagi, Alka
    Tyagi, Neetu
    MOLECULAR NEUROBIOLOGY, 2014, 49 (01) : 590 - 600
  • [23] Hypoxia and brain aging: Neurodegeneration or neuroprotection?
    Burtscher, Johannes
    Mallet, Robert T.
    Burtscher, Martin
    Millet, Gregoire P.
    AGEING RESEARCH REVIEWS, 2021, 68
  • [24] Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration
    Gomes, Catarina V.
    Kaster, Manuella P.
    Tome, Angelo R.
    Agostinho, Paula M.
    Cunha, Rodrigo A.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2011, 1808 (05): : 1380 - 1399
  • [25] Catechin polyphenols: Neurodegeneration and neuroprotection in neurodegenerative diseases
    Mandel, S
    Youdim, MBH
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (03) : 304 - 317
  • [26] One-carbon epigenetics and redox biology of neurodegeneration
    Coppede, Fabio
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 170 : 19 - 33
  • [27] Topical Review: The Emerging Field of Epigenetics: Informing Models of Pediatric Trauma and Physical Health
    Nugent, Nicole R.
    Goldberg, Amy
    Uddin, Monica
    JOURNAL OF PEDIATRIC PSYCHOLOGY, 2016, 41 (01) : 55 - 64
  • [28] Neuronal dark matter: the emerging role of microRNAs in neurodegeneration
    Goodall, Emily F.
    Heath, Paul R.
    Bandmann, Oliver
    Kirby, Janine
    Shaw, Pamela J.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2013, 7
  • [29] Epigenetics: An emerging player in gastric cancer
    Changwon Kang
    Ji-Joon Song
    Jaeok Lee
    Mi Young Kim
    World Journal of Gastroenterology, 2014, (21) : 6433 - 6447
  • [30] Cytochrome c Oxidase and Its Role in Neurodegeneration and Neuroprotection
    Arnold, Susanne
    MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION: NUCLEAR-ENCODED GENES, ENZYME REGULATION, AND PATHOPHYSIOLOGY, 2012, 748 : 305 - 339